Cargando…
Clinicopathologic characteristics and prognostic significance of HER2-low expression in patients with early breast cancer: A systematic review and meta-analysis
BACKGROUND: HER2-low expression breast cancer (BC) accounts for approximately 45%-55% of all BC cases. The purpose of this study was to investigate the prognostic difference between patients with HER2-low expression and HER2-zero BC. METHODS: An electronic search of Pubmed, Embase, Cochrane Library,...
Autores principales: | Wei, Tong, Wang, Dingyuan, Gao, Songlin, Wang, Xue, Yue, Jian, Kang, Yikun, Ju, Jie, Yang, Zixuan, Shuai, You, Yuan, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931719/ https://www.ncbi.nlm.nih.gov/pubmed/36816954 http://dx.doi.org/10.3389/fonc.2023.1100332 |
Ejemplares similares
-
Liquid-based biomarkers in breast cancer: looking beyond the blood
por: Shuai, You, et al.
Publicado: (2023) -
Prognostic and Clinicopathological Significance of E-Cadherin in Pancreatic Cancer Patients: A Meta-Analysis
por: Wang, Pengbo, et al.
Publicado: (2021) -
Clinicopathological Characteristics and Prognosis of HER2-Low Early-Stage Breast Cancer: A Single-Institution Experience
por: Xu, Hangcheng, et al.
Publicado: (2022) -
Clinicopathological and prognostic significance of HER-2/neu and VEGF expression in colon carcinomas
por: Li, Qingguo, et al.
Publicado: (2011) -
Computed Tomography Features and Clinicopathological Characteristics of Gastric Sarcomatoid Carcinoma
por: Liu, Yi-yang, et al.
Publicado: (2020)